Keith Katkin

Insider Reports History

Location
Irvine, CA
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Keith Katkin:

Company Role Class Num Shares Value Price $ Report Date Ownership
Syndax Pharmaceuticals Inc Director Common Stock 100,000 $911,200 $9.11 19 May 2025 Direct
Emergent BioSolutions Inc. Director Common Stock 86,431 $544,515 $6.3 23 May 2025 Direct
RIGEL PHARMACEUTICALS INC Director Common Stock 25,000 $43,750 $1.75 19 May 2021 Direct
Eledon Pharmaceuticals, Inc. Director Stock Option (right to buy) 77,175 10 Jan 2025 Direct
Emergent BioSolutions Inc. Director Stock Option (Right to Buy) 41,572 30 Apr 2025 Direct
RIGEL PHARMACEUTICALS INC Director Stock Option (Right to Buy) 30,000 19 May 2021 Direct
Eledon Pharmaceuticals, Inc. Director Restricted Stock Units 8,575 10 Jan 2025 Direct

Insider Reports Filed by Keith Katkin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EBS Emergent BioSolutions Inc. 23 May 2025 1 -$49,417 4 Director 28 May 2025, 16:08
SNDX Syndax Pharmaceuticals Inc 19 May 2025 1 $91,120 4 Director 19 May 2025, 16:01
EBS Emergent BioSolutions Inc. 30 Apr 2025 2 $0 4 Director 02 May 2025, 20:30
SNDX Syndax Pharmaceuticals Inc 05 Feb 2025 1 $0 4 Director 07 Feb 2025, 16:37
ELDN Eledon Pharmaceuticals, Inc. 10 Jan 2025 2 $0 4 Director 13 Jan 2025, 17:30
EBS Emergent BioSolutions Inc. 23 May 2024 2 $0 4 Director 28 May 2024, 21:41
SNDX Syndax Pharmaceuticals Inc 07 Feb 2024 1 $0 4 Director 09 Feb 2024, 16:04
EBS Emergent BioSolutions Inc. 25 May 2023 1 $0 4 Director 30 May 2023, 19:05
ELDN Eledon Pharmaceuticals, Inc. 01 May 2023 1 $0 4 Director 02 May 2023, 18:45
SNDX Syndax Pharmaceuticals Inc 02 Feb 2023 1 $0 4 Director 03 Feb 2023, 15:52
ELDN Eledon Pharmaceuticals, Inc. 01 Feb 2023 1 $0 4 Director 02 Feb 2023, 17:04
SNDX Syndax Pharmaceuticals Inc 06 Oct 2022 6 -$529,234 4 Director 07 Oct 2022, 16:05
SNDX Syndax Pharmaceuticals Inc 30 Sep 2022 18 -$69,533 4 Director 04 Oct 2022, 17:49
EBS Emergent BioSolutions Inc. 02 Apr 2022 1 $0 4 Director 05 Apr 2022, 16:22
EBS Emergent BioSolutions Inc. 01 Apr 2022 0 $0 3 Director 05 Apr 2022, 16:18
SNDX Syndax Pharmaceuticals Inc 02 Feb 2022 1 $0 4 Director 03 Feb 2022, 16:30
ELDN Eledon Pharmaceuticals, Inc. 01 Feb 2022 1 $0 4 Director 02 Feb 2022, 16:30
RIGL RIGEL PHARMACEUTICALS INC 19 May 2021 2 $0 4 Director 21 May 2021, 20:57